조영제 시장 규모, 점유율, 성장 분석 : 유형별, 형태별, 모달리티별, 투여 경로별, 적응증별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Contrast Media Market Size, Share, and Growth Analysis, By Type, By Form, By Modality, By Route of Administration, By Indication, By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1701698
리서치사:SkyQuest
발행일:2025년 04월
페이지 정보:영문 260 Pages
라이선스 & 가격 (부가세 별도)
한글목차
조영제 시장 규모는 2023년에 69억 달러로 평가되며, 2024년 74억 6,000만 달러에서 2032년에는 139억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 8.1%로 성장할 전망입니다.
조영제 시장은 현재 만성질환의 유병률 증가, 영상 기술의 발전, 영상 진단 기술 증가 등의 영향을 받고 있습니다. 하지만, 특히 알레르기 반응과 같은 안전성 우려와 조영제 관련 높은 비용이 성장의 걸림돌로 작용하고 있으며, 개발도상국에서의 도입이 제한적일 수 있습니다. 이러한 과제에도 불구하고 시장은 조영제 개발의 기술 혁신, 기술 통합 강화, 신흥 시장 확대에 힘입어 꾸준한 성장이 예상됩니다. 이러한 추세는 이해관계자들에게 안전과 가격 문제를 해결하면서 진보를 활용하고 증가하는 수요에 대응할 수 있는 기회를 제공합니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술 분석
조영제 시장 규모 : 유형별
시장 개요
요오드화 조영제
가돌리늄 기반 조영제
마이크로버블 조영제
바륨계 조영제
조영제 시장 규모 : 형태별
시장 개요
액체
분말
기타 형식
조영제 시장 규모 : 모달리티별
시장 개요
X선
컴퓨터 단층촬영(CT)
자기공명영상(MRI)
초음파
조영제 시장 규모 : 투여 경로별
시장 개요
혈관내 경로
경구투여
직장 경로
기타 투여 경로
조영제 시장 규모 : 적응증별
시장 개요
심혈관질환
암
위장 장애
근골격계 장애
신경질환
신장질환
조영제 시장 규모 : 용도별
시장 개요
방사선과
인터벤션 영상의학
IC(Interventional Cardiology)
조영제 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024년)
주요 기업 개요
Bayer AG(Germany)
GE Healthcare(USA)
Bracco Imaging S.p.A.(Italy)
Guerbet(France)
Lantheus Holdings, Inc.(USA)
Merck KGaA(Germany)
FUJIFILM Corporation(Japan)
Taejoon Pharm Co., Ltd.(South Korea)
Beijing Beilu Pharmaceutical Co., Ltd.(China)
Nano Therapeutics Pvt. Ltd.(India)
CMC Contrast AB(Sweden)
Imax Diagnostic Imaging(Canada)
Trivitron Healthcare(India)
Fresenius Kabi(Germany)
Sanochemia Pharmazeutika AG(Austria)
J.B. Chemicals & Pharmaceuticals Ltd.(India)
Jodas Expoim Pvt. Ltd.(India)
Livealth Biopharma(China)
Spago Nanomedical AB(Sweden)
Subhra Pharma Pvt. Ltd.(India)
결론과 제안
KSA
영문 목차
영문목차
Contrast Media Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 7.46 billion in 2024 to USD 13.91 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
The contrast media market is currently influenced by a rising prevalence of chronic diseases, advances in imaging technologies, and an increase in diagnostic imaging procedures. However, growth is hindered by safety concerns, particularly regarding allergic reactions, and the high costs associated with contrast agents, which can limit adoption in developing regions. Despite these challenges, the market is expected to experience steady growth driven by innovations in contrast agent development, enhanced technological integration, and expanding markets. These trends present opportunities for stakeholders to capitalize on advancements and cater to growing demand while addressing safety and affordability issues.
Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Contrast Media Market Segments Analysis
Global Contrast Media Market is segmented by Type, Form, Modality, Route of Administration, Indication, Application and region. Based on Type, the market is segmented into Iodinated contrast media, Gadolinium-based contrast media, Microbubble contrast media and Barium-based contrast media. Based on Form, the market is segmented into Liquid, Powder and Other forms. Based on Modality, the market is segmented into X-ray, Computed tomography (CT), Magnetic resonance imaging (MRI) and Ultrasound. Based on Route of Administration, the market is segmented into Intravascular route, Oral route, Rectal route and Other routes of administration. Based on Indication, the market is segmented into Cardiovascular disease, Cancer, Gastrointestinal disorders, Musculoskeletal disorders, Neurological disorders and Nephrological disorders. Based on Application, the market is segmented into Radiology, Interventional radiology, Interventional cardiology. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Contrast Media Market
The Contrast Media market is primarily driven by an increasing awareness among patients about the critical role of diagnostic imaging in managing and detecting diseases, leading to a heightened demand for contrast agents. Additionally, the advocacy from healthcare professionals significantly contributes to market growth, as medical practitioners are increasingly acknowledging the value and benefits of contrast-enhanced imaging in achieving accurate diagnoses and outcomes. This recognition has translated into a surge in the number of prescriptions for these agents, further fuelling the expansion of the Contrast Media market as both patients and providers seek to enhance diagnostic effectiveness.
Restraints in the Contrast Media Market
The growth of the Contrast Media market is significantly hindered in many developing regions due to a limited number of healthcare professionals and inadequate access to advanced technologies and facilities. Furthermore, the lack of awareness about the benefits and applications of contrast media can impede market expansion. Additionally, insufficient training for medical practitioners regarding the use of contrast agents and their associated imaging techniques further restricts adoption. These factors collectively contribute to a challenging environment for the growth of the contrast media market, as they prevent effective utilization and understanding of these critical imaging tools within the healthcare sector.
Market Trends of the Contrast Media Market
The Contrast Media market is witnessing a significant trend towards improved safety profiles, driven by advancements in gadolinium-based contrast agents. Research focusing on minimizing nephrogenic systemic fibrosis (NSF) risks has led to the development of novel agents that emphasize reduced gadolinium retention. This shift is pushing healthcare providers to favor agents with enhanced safety features, which are particularly beneficial for patients with compromised renal function. Additionally, the adoption of non-ionic low osmolar contrast agents in computed tomography is gaining traction, as they effectively minimize side effects. This evolving landscape highlights a growing preference for safer, more effective contrast media solutions among healthcare professionals.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Global Contrast Media Market Size by Type & CAGR (2025-2032)
Market Overview
Iodinated contrast media
Gadolinium-based contrast media
Microbubble contrast media
Barium-based contrast media
Global Contrast Media Market Size by Form & CAGR (2025-2032)
Market Overview
Liquid
Powder
Other forms
Global Contrast Media Market Size by Modality & CAGR (2025-2032)
Market Overview
X-ray
Computed tomography (CT)
Magnetic resonance imaging (MRI)
Ultrasound
Global Contrast Media Market Size by Route of Administration & CAGR (2025-2032)
Market Overview
Intravascular route
Oral route
Rectal route
Other routes of administration
Global Contrast Media Market Size by Indication & CAGR (2025-2032)
Market Overview
Cardiovascular disease
Cancer
Gastrointestinal disorders
Musculoskeletal disorders
Neurological disorders
Nephrological disorders
Global Contrast Media Market Size by Application & CAGR (2025-2032)
Market Overview
Radiology
Interventional radiology
Interventional cardiology
Global Contrast Media Market Size & CAGR (2025-2032)
North America (Type, Form, Modality, Route of Administration, Indication, Application)
US
Canada
Europe (Type, Form, Modality, Route of Administration, Indication, Application)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Form, Modality, Route of Administration, Indication, Application)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Form, Modality, Route of Administration, Indication, Application)
Brazil
Rest of Latin America
Middle East & Africa (Type, Form, Modality, Route of Administration, Indication, Application)
